Articles related to GUIDELINES/RECOMMENDATIONS

Analysis of NHANES data suggests that adoption of the 2026 ACC/AHA dyslipidemia guidelines could make approximately 25 million additional US adults eligible to consider statin therapy, primarily through incorporation of PREVENT risk equations and expanded emphasis on long-term cardiovascular risk.

Updated AAN and AHS guidance outlines when to initiate preventive migraine therapy, how to select treatments based on efficacy and tolerability, and how to tailor management for special populations and comorbidities.

Updated joint ESPGHAN/NASPGHAN guidelines for pediatric Helicobacter pylori infection emphasize antimicrobial stewardship, susceptibility-guided therapy, and more selective testing strategies. The recommendations also introduce several changes regarding screening, incidental findings, and management of associated conditions.

The American Academy of Pediatrics expanded its definition of children at high risk for severe RSV disease who should receive immunization before their second RSV season, adding several congenital, developmental, and prematurity-related conditions to existing eligibility criteria.

This review outlines a practical approach to headache imaging, emphasizing that MRI is preferred over CT in most nonemergent settings, while contrast-enhanced MRI should be reserved for specific red-flag scenarios such as malignancy, immunosuppression, focal neurologic deficits, intracranial pressure disorders, infection, and trigeminal autonomic cephalalgias.

New consensus guidance favors once-daily oral iron and simplified IV administration, including fewer test doses, premedications, and infusion visits. Several recommendations depart from established protocols and require formulation-specific clinical judgment.